Clinical Trial Update: A Study to Assess Long-term Outcomes of Myocarditis Following Administration of COVID-19 mRNA Vaccine (SPIKEVAX)

View source ↗

Summary

This clinical trial update describes a study evaluating long-term outcomes of myocarditis that occurred after vaccination with Spikevax (mRNA-1273) from Moderna…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocarditis

Drugs mentioned

• Spikevax (mRNA-1273)

Snippet

Sponsor: ModernaTX, Inc. | Conditions: Myocarditis | Status: ACTIVE_NOT_RECRUITING